Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Retinoblastoma × Etoposide × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 18 Lymphoma, Large B-Cell, Diffuse 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Medulloblastoma 7 Lung Neoplasms 7 Burkitt Lymphoma 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Sarcoma, Ewing 5 Recurrence 5 Brain Neoplasms 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Hodgkin Disease 4 Ependymoma 4 Carcinoma, Non-Small-Cell Lung 4 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell 3 Glioblastoma 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Leukemia 2 Glioma 2

Interventions

Watchful Waiting 1 Vincristine 1 Thiotepa 1 Surveys and Questionnaires 1 Observation 1 LY2940680 1 Etoposide 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Cytapheresis 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡